标题
Erdafitinib Antagonizes ABCB1-Mediated Multidrug Resistance in Cancer Cells
作者
关键词
-
出版物
Frontiers in Oncology
Volume 10, Issue -, Pages -
出版商
Frontiers Media SA
发表日期
2020-06-25
DOI
10.3389/fonc.2020.00955
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Medicinal chemistry strategies to discover P-glycoprotein inhibitors: An update
- (2020) Jinyun Dong et al. DRUG RESISTANCE UPDATES
- The PI3K subunits, P110α and P110β are potential targets for overcoming P-gp and BCRP-mediated MDR in cancer
- (2020) Lei Zhang et al. Molecular Cancer
- Mechanical Changes and Microfilament Reorganization Involved in Microcystin-LR-Promoted Cell Invasion in DU145 and WPMY Cells
- (2020) Qiang Zhang et al. Frontiers in Pharmacology
- Venetoclax, a BCL-2 Inhibitor, Enhances the Efficacy of Chemotherapeutic Agents in Wild-Type ABCG2-Overexpression-Mediated MDR Cancer Cells
- (2020) Jing-Quan Wang et al. Cancers
- Biological evaluation of non-basic chalcone CYB-2 as a dual ABCG2/ABCB1 inhibitor
- (2020) Chao-Yun Cai et al. BIOCHEMICAL PHARMACOLOGY
- M3814, a DNA-PK Inhibitor, Modulates ABCG2-Mediated Multidrug Resistance in Lung Cancer Cells
- (2020) Zhuo-Xun Wu et al. Frontiers in Oncology
- Ciprofloxacin Enhances the Chemosensitivity of Cancer Cells to ABCB1 Substrates
- (2019) Pranav Gupta et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Inhibitors of Human ABCG2: From Technical Background to Recent Updates With Clinical Implications
- (2019) Yu Toyoda et al. Frontiers in Pharmacology
- Avapritinib, a selective inhibitor of KIT and PDGFRα reverses ABCB1 and ABCG2-mediated multidrug resistance in cancer cell lines
- (2019) Chung-Pu Wu et al. MOLECULAR PHARMACEUTICS
- Glesatinib, a c-MET/SMO Dual Inhibitor, Antagonizes P-glycoprotein Mediated Multidrug Resistance in Cancer Cells
- (2019) Qingbin Cui et al. Frontiers in Oncology
- Tepotinib reverses ABCB1-mediated multidrug resistance in cancer cells
- (2019) Zhuo-Xun Wu et al. BIOCHEMICAL PHARMACOLOGY
- Derivative of 5-cyano-6-phenylpyrimidin antagonizes ABCB1- and ABCG2-mediated multidrug resistance
- (2019) Jing-Quan Wang et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Tetrandrine Interaction with ABCB1 Reverses Multidrug Resistance in Cancer Cells Through Competition with Anti-Cancer Drugs Followed by Downregulation of ABCB1 Expression
- (2019) Dan Liao et al. MOLECULES
- Targeting the ubiquitin-proteasome pathway to overcome anti-cancer drug resistance
- (2019) Silpa Narayanan et al. DRUG RESISTANCE UPDATES
- The Selective Class IIa Histone Deacetylase Inhibitor TMP195 Resensitizes ABCB1- and ABCG2-Overexpressing Multidrug-Resistant Cancer Cells to Cytotoxic Anticancer Drugs
- (2019) Chung-Pu Wu et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Epidermal growth factor receptor (EGFR) inhibitor PD153035 reverses ABCG2-mediated multidrug resistance in non-small cell lung cancer: In vitro and in vivo
- (2018) Guan-Nan Zhang et al. CANCER LETTERS
- Tyrosine kinase inhibitors enhanced the efficacy of conventional chemotherapeutic agent in multidrug resistant cancer cells
- (2018) Shaocong Wu et al. Molecular Cancer
- Ulixertinib (BVD-523) antagonizes ABCB1- and ABCG2-mediated chemotherapeutic drug resistance
- (2018) Ning Ji et al. BIOCHEMICAL PHARMACOLOGY
- Selonsertib (GS-4997), an ASK1 inhibitor, antagonizes multidrug resistance in ABCB1- and ABCG2-overexpressing cancer cells
- (2018) Ning Ji et al. CANCER LETTERS
- Outcomes of 219 chronic myeloid leukaemia patients with additional chromosomal abnormalities and/or tyrosine kinase domain mutations
- (2018) Mingming Xue et al. International Journal of Laboratory Hematology
- Olmutinib (BI1482694/HM61713), a Novel Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor, Reverses ABCG2-Mediated Multidrug Resistance in Cancer Cells
- (2018) Wei Zhang et al. Frontiers in Pharmacology
- Immuno-oncology agent IPI-549 is a modulator of P-glycoprotein (P-gp, MDR1, ABCB1)-mediated multidrug resistance (MDR) in cancer: In vitro and in vivo
- (2018) Albert A. De Vera et al. CANCER LETTERS
- Overcoming ABC transporter-mediated multidrug resistance: The dual role of tyrosine kinase inhibitors as multitargeting agents
- (2017) Giovanni Luca Beretta et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Discovery and Pharmacological Characterization of JNJ-42756493 (Erdafitinib), a Functionally Selective Small-Molecule FGFR Family Inhibitor
- (2017) Timothy P.S. Perera et al. MOLECULAR CANCER THERAPEUTICS
- Overcoming ABC transporter-mediated multidrug resistance: Molecular mechanisms and novel therapeutic drug strategies
- (2016) Wen Li et al. DRUG RESISTANCE UPDATES
- Osimertinib (AZD9291) Attenuates the Function of Multidrug Resistance-Linked ATP-Binding Cassette Transporter ABCB1 in Vitro
- (2016) Sung-Han Hsiao et al. MOLECULAR PHARMACEUTICS
- Molecular mechanisms of drug resistance and its reversal in cancer
- (2015) Melis Kartal-Yandim et al. CRITICAL REVIEWS IN BIOTECHNOLOGY
- Coexpression of Multiple ABC-Transporters is Strongly Associated with Treatment Response in Childhood Acute Myeloid Leukemia
- (2015) Stephan Bartholomae et al. PEDIATRIC BLOOD & CANCER
- DNA repair mechanisms in cancer development and therapy
- (2015) Alessandro Torgovnick et al. Frontiers in Genetics
- Multi-drug resistance in cancer chemotherapeutics: Mechanisms and lab approaches
- (2014) Qiong Wu et al. CANCER LETTERS
- The pharmacological impact of ATP-binding cassette drug transporters on vemurafenib-based therapy
- (2014) Chung-Pu Wu et al. Acta Pharmaceutica Sinica B
- MDR1 Synonymous Polymorphisms Alter Transporter Specificity and Protein Stability in a Stable Epithelial Monolayer
- (2013) King Leung Fung et al. CANCER RESEARCH
- Interaction of the Efflux Transporters ABCB1 and ABCG2 With Imatinib, Nilotinib, and Dasatinib
- (2013) L N Eadie et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Changing the expression vector of multidrug resistance genes is related to neoadjuvant chemotherapy response
- (2012) Nicolay V. Litviakov et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- ABC Efflux Pump-Based Resistance to Chemotherapy Drugs
- (2009) Paul D. W. Eckford et al. CHEMICAL REVIEWS
- AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading
- (2009) Oleg Trott et al. JOURNAL OF COMPUTATIONAL CHEMISTRY
- Substrate-Dependent Breast Cancer Resistance Protein (Bcrp1/Abcg2)-Mediated Interactions: Consideration of Multiple Binding Sites in in Vitro Assay Design
- (2008) N. Giri et al. DRUG METABOLISM AND DISPOSITION
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started